KSB represents Glenmark Pharmaceuticals in acquisition of Medicamenta
Glenmark Pharmaceuticals Ltd. is the Indian leader in the development of newmolecules in mainly inflammation and metabolic disorders. The company operatesin more than eighty countries worldwide and the acquisition of Medicamenta a.s.represents a strategic entry into two of the fastest growing markets in the EU.
Other articles
KŠB Advises PPF on Landmark Cross-Border Conversion to the Czech Republic
Kocián Šolc Balaštík provided comprehensive legal counsel to the PPF Group in connection with the cross-border conversion of its holding structure from the Netherlands to the Czech Republic. KŠB’s team, led by partner Jan Lasák, played a central role with structuring the reorganisation and preparing the key documentation.
KŠB ranked among the largest law firms in the Czech Republic by Forbes
Kocián Šolc Balaštík has been ranked among the largest law firms in the Czech Republic in the Forbes overview of leading legal practices, based on revenues over the past three years.
KŠB Ranked in Legal 500 2026
Following our success in last week’s Chambers Europe Guide, we are pleased to confirm our position among the leading law firms in the Czech Republic also in the Legal 500 2026 rankings published by Legal 500.
